Aidigong Maternal & Child Health Limited (0286.HK)

Aidigong Maternal & Child Health Limited (0286.HK) — VMCI valuation read

Composite valuation read on 0286.HK: VMCI 41/100 against a Healthcare sector median of 50. The 9-point below-median print is the headline number for Aidigong Maternal & Child Health Limited, and at the mid-cap tier it reflects how the five pillars combine into a single decision-grade score.

Trailing 30-day insider activity for 0286.HK: nothing material on SEC EDGAR. With the Form 4 channel quiet, the price-vs-DCF gap and the trailing margin trend carry more weight in the active read.

**Investor frame.** Value, quality, risk in three lines on 0286.HK: 0286.HK trades at 19.0x earnings, 6% above the Healthcare median of 18.0x; ROIC of 17.0% sits 7.0pp above the Healthcare median (10.0%); net debt to EBITDA of 2.9x is the rate-sensitivity line to watch. EV/EBITDA at 14.0x versus 12.0x for Healthcare closes the value frame.

0286.HK rose 2.6% over the trailing 7 days, with a -20.2% read on a 30-day basis.